Auna S.A. and its health‑plan arm Oncosalud S.A.C. announced a private placement of senior secured notes due 2032. The offering will be structured under Rule 144A, Regulation S, and Section 4(a)(2) of the Securities Act, and the notes will be fully and unconditionally guaranteed on a senior secured basis by certain subsidiaries of Auna and Oncosalud.
Proceeds from the new notes will be used to fund a tender offer for the company’s outstanding 10.000% senior secured notes due 2029, prepay indebtedness under the credit agreement dated November 10 2023, and cover related interest, fees and expenses. The tender offer for the 2029 notes offers $1,020 per $1,000 of notes tendered, plus an additional $50 early‑tender payment for notes submitted by October 31 2025. The offer runs until November 18 2025, with early settlement on November 6 2025 and final settlement on November 21 2025.
As of December 23 2024, the aggregate principal amount outstanding of the 2029 notes was $310,837,161. The credit agreement dated November 10 2023 secured a $550 million term loan that closed on December 18 2023. The new 2032 notes will help refinance that debt and support Auna’s capital structure across its operations in Mexico, Peru and Colombia.
Citigroup Global Markets Inc., HSBC Securities (USA) Inc., and Santander US Capital Markets LLC are acting as dealer managers for the tender offer. The new notes offering will be managed by the same financial institutions.
The transaction is part of Auna’s ongoing debt‑management strategy, following a 2023 exchange offer of 6.500% senior notes due 2025 for new 10.000% senior secured notes due 2029 and a $550 million secured term loan. The company’s issuer credit rating was upgraded to B+ in December 2023.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.